glp-1 blindness GLP 1 Risk GLP-1s and Eye Health: What
Description
Gone are the days of a one-size-fits-all solution to overall wellness
In this study, once-weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, or 15 mg) were compared to once-daily subcutaneous injections of titrated insulin degludec
If successful, they could dramatically improve convenience and potentially increase treatment uptake
Taking a GLP-1 has also made me feel energized for the first time in a while
n = 88 of 4,672 patients, respectively
